Short interest in CARISMA Therapeutics Inc (NASDAQ:CARM) decreased during the last reporting period, falling from 484.88K to 324.34K. This put 0.97% of the company's publicly available shares short.

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. This medical device company has seen a nice streak of beating earnings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended ...

The sensation is called globus. The feeling can last for a few minutes to several days and sometimes causes pain, but it's more often described as being an uncomfortable annoyance. It’s important to ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Globus Spirits Ltd share price was up by 3.06% from the previous closing price of ₹983.40. Who are peers of Globus Spirits Ltd? The peers of Globus Spirits Ltd are United Spirits Ltd, United ...

Globus intends to discuss the expected benefits of the expanded product offerings in its first quarter earnings conference. Credit: T Schneider / Shutterstock. Globus Medical has completed its ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro. In February, Audobon, Pennsylvania-based Globus agreed to acquire all shares of ...

GLOBUS SPIRITS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve Financial Results for the 2nd quarter and ...